Autoantibody profile in individuals with chronic hepatitis C

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 46, Issue 2, 2013, Pages 147-153

  Marconcini, Maíra Luciana ^a   Fayad, Leonardo ^a   Shiozawa, Maria Beatriz Cacese ^a   Dantas Correa, Esther Buzaglo ^a   De Lucca Schiavon, Leonardo ^a   Narciso Schiavon, Janaína Luz ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Autoimmunity; Celiac disease; Cryoglobulins; Hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; CRYOGLOBULIN; ENDOMYSIUM ANTIBODY; LIVER KIDNEY MICROSOMAL TYPE 1 ANTIBODY; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTHROMBIN; SMOOTH MUSCLE ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE COUNT; VIRUS LOAD;

AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 84877975372     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0039-2013     Document Type: Article

References (54)

1. World Health Organization (WHO). Hepatitis C - 2002. Geneva: WHO; 2003
2. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325:98-104
3. Thein HH, Yi Q, Dore GJ, Krahn MD. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 2008; 48:418-431
4. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14:4300-4308
5. Obermayer-Straub P, Manns MP. Hepatitis C and D, retroviruses and autoimmune manifestations. J Autoimm 2001; 16:275-285
6. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21:613-619
7. Bogdanos DP, McFarlane IG. Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. J Hepatol 2003; 39:860-863
8. Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335:258-259
9. Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15:225-232
10. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26:561-566
11. Narciso-Schiavon JL, Freire FC, Suarez MM, Ferrari MV, Scanhola GQ, Schiavon LL, et al. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon? Eur J Gastroenterol Hepatol 2009; 21:440-446
12. Yee LJ, Kelleher P, Goldin RD, Marshall S, Thomas HC, Alberti A, et al. Antinuclear antibodies in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. J Viral Hepat 2004; 11:459-464
13. Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E, Agostoni A, et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 2000; 7:138-143
14. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106:1291-1300
15. Ruggeri C, La Masa AT, Rudi S, Squadrito G, Di Pasquale G, Maimone S, et al. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2008; 53:2151-2155
16. Durante-Mangoni E, Iardino P, Resse M, Cesaro G, Sica A, Farzati B, et al. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 2004; 38:901-905
17. Thevenot T, Denis J, Jouannaud V, Monnet E, Renou C, Labadie H, et al. Celiac disease in chronic hepatitis C: a French multicentre prospective study. Aliment Pharmacol Ther 2007; 26:1209-1216
18. Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 1995; 132:587-593
19. Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs. hepatitis before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158:1445-1448
20. Gayotto LCC. Visão histórica e consenso nacional sobre a classificação das hepatites crônicas. Comitê da Sociedade Brasileira de Patologia e da Sociedade Brasileira de Hepatologia. Gastroenterol Endosc Dig 2000; 19:137-140
21. Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Aids, DST e hepatites virais. Boletim Epidemiológico Hepatites Virais. Brasília: Ministério da Saúde; 2011. p. 1-82
22. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000; 31:756-762
23. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906-1911
24. Andrade LJ, Melo PR, Atta AM, Atta ML, Jesus LS, Sousa GM, et al. Smooth muscle antibodies and cryoglobulinemia are associated with advanced liver fibrosis in Brazilian hepatitis C virus carriers. Braz J Infect Dis 2011; 15:66-68
25. Relatório do Grupo de Estudo da Sociedade Brasileira de Hepatologia. Epidemiologia da infecção pelo vírus da hepatite C no Brasil. Gastroenterol Endosc Dig 1999; 18:53-58
26. Ganne-Carrie N, Medini A, Coderc E, Seror O, Christidis C, Grimbert S, et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 2000; 14:189-193
27. Duclos-Vallee JC, Pateron D, Joannet C, Duron F, Homber JC, Beaugrand M. High prevalence of anti-HCV antibodies in patients with Hashimoto's thyroiditis. BMJ 1994; 309:846-847
28. Yang R, Shan Z, Li Y, Fan C, Li C, Teng W. Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China. Intern Med 2011; 50:811-815
29. Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J, Weinstein J. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001; 96:138-145
30. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40:2007-2015
31. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994; 106:1291-1300
32. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104:25-31
33. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996; 28:1-9
34. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. J Hepatol 1993; 18:342-352
35. Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, et al. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004; 11:257-262
36. Muratori P, Muratori L, Guidi M, Granito A, Susca M, Lenzi M, et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005; 40:501-507
37. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. Prevalence on non-organ specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysus cohort. Gut 1999; 45:435-441
38. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:998-1005
39. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51:2193-2213
40. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38:621-628
41. Zusinaite E, Metskula K, Salupere R. Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia. World J Gastroenterol 2005; 11:488-491
42. Wandstrat A, Carr-Johnson F, Branch V, Gray H, Fairhurst A, et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006; 27:153-160
43. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapää- Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011; 13:2-8
44. Hilário MO, Len CA, Roja SC, Terreri MT, Almeida G, Andrade LE. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr 2004; 43:637-642
45. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 1997; 42:1688-1696
46. Hietarinta M, Lassila O. Clinical significance of antinuclear antibodies in systemic rheumatic diseases. Ann Med 1996; 28:283-291
47. Peng YC, Hsieh SC, Yang DY, Tung CF, Hu WH, Huang WN, et al. Expression and Clinical Significance of Antinuclear Antibody in Hepatitis C Virus Infection. J Clin Gastroenterol 2001; 33:402-406
48. Zauli D, Cassani F, Bianchi FB. Auto-antibodies in hepatitis C. Biomed Pharmacother 1999; 53:234-241
49. White RH, Robbins DL. Clinical significance and interpretation of antinuclear antibodies. West J Med 1987;147:210-213
50. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994; 107:200-207
51. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. l. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993; 18:359-364
52. Muratori P, Muratori L, Stroffolini T, Pappas G, Terlizzi P, Ferrari R, et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 2003;131:118-121
53. Chrétien P, Chousterman M, Abd Alsamad I, Ozenne V, Rosa I, Barrault C, et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun 2009; 32:201-205
54. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108:157-164.